ASTRAZENECA PLC (ZEG.DE) Stock Fundamental Analysis
Europe - FRA:ZEG - GB0009895292 - Common Stock
131.65 EUR
+0.8 (+0.61%)
ZEG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 49 industry peers in the Pharmaceuticals industry. While ZEG has a great profitability rating, there are quite some concerns on its financial health. ZEG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ZEG was profitable.
ZEG had a positive operating cash flow in the past year.
Each year in the past 5 years ZEG has been profitable.
In the past 5 years ZEG always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.38%, ZEG is in the better half of the industry, outperforming 61.22% of the companies in the same industry.
With a decent Return On Equity value of 18.55%, ZEG is doing good in the industry, outperforming 65.31% of the companies in the same industry.
ZEG has a Return On Invested Capital of 14.26%. This is in the better half of the industry: ZEG outperforms 75.51% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ZEG is below the industry average of 15.25%.
The 3 year average ROIC (11.62%) for ZEG is below the current ROIC(14.26%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.38% | ||
| ROE | 18.55% | ||
| ROIC | 14.26% |
ROA(3y)5.35%
ROA(5y)4.19%
ROE(3y)13.78%
ROE(5y)12.42%
ROIC(3y)11.62%
ROIC(5y)9.52%
1.3 Margins
Looking at the Profit Margin, with a value of 14.68%, ZEG is in the better half of the industry, outperforming 65.31% of the companies in the same industry.
ZEG's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 24.39%, ZEG is doing good in the industry, outperforming 65.31% of the companies in the same industry.
In the last couple of years the Operating Margin of ZEG has grown nicely.
The Gross Margin of ZEG (82.07%) is better than 81.63% of its industry peers.
ZEG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.39% | ||
| PM (TTM) | 14.68% | ||
| GM | 82.07% |
OM growth 3Y21.43%
OM growth 5Y8.6%
PM growth 3Y251.6%
PM growth 5Y18.9%
GM growth 3Y3.31%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZEG is creating some value.
ZEG has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ZEG has more shares outstanding
The debt/assets ratio for ZEG is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.25 indicates that ZEG is not in any danger for bankruptcy at the moment.
ZEG's Altman-Z score of 5.25 is fine compared to the rest of the industry. ZEG outperforms 77.55% of its industry peers.
The Debt to FCF ratio of ZEG is 4.01, which is a neutral value as it means it would take ZEG, 4.01 years of fcf income to pay off all of its debts.
ZEG has a Debt to FCF ratio (4.01) which is comparable to the rest of the industry.
ZEG has a Debt/Equity ratio of 0.63. This is a neutral value indicating ZEG is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, ZEG perfoms like the industry average, outperforming 51.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 4.01 | ||
| Altman-Z | 5.25 |
ROIC/WACC1.61
WACC8.86%
2.3 Liquidity
A Current Ratio of 0.86 indicates that ZEG may have some problems paying its short term obligations.
ZEG's Current ratio of 0.86 is on the low side compared to the rest of the industry. ZEG is outperformed by 79.59% of its industry peers.
A Quick Ratio of 0.67 indicates that ZEG may have some problems paying its short term obligations.
The Quick ratio of ZEG (0.67) is worse than 79.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.30% over the past year.
The Earnings Per Share has been growing by 18.59% on average over the past years. This is quite good.
Looking at the last year, ZEG shows a quite strong growth in Revenue. The Revenue has grown by 15.00% in the last year.
ZEG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.27% yearly.
EPS 1Y (TTM)22.3%
EPS 3Y15.85%
EPS 5Y18.59%
EPS Q2Q%9.6%
Revenue 1Y (TTM)15%
Revenue growth 3Y13.06%
Revenue growth 5Y17.27%
Sales Q2Q%11.74%
3.2 Future
Based on estimates for the next years, ZEG will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.18% on average per year.
The Revenue is expected to grow by 6.76% on average over the next years.
EPS Next Y13.69%
EPS Next 2Y13.68%
EPS Next 3Y12.68%
EPS Next 5Y12.18%
Revenue Next Year9.68%
Revenue Next 2Y7.88%
Revenue Next 3Y7.14%
Revenue Next 5Y6.76%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.65, ZEG is valued on the expensive side.
ZEG's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of ZEG to the average of the S&P500 Index (27.20), we can say ZEG is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.69, the valuation of ZEG can be described as correct.
ZEG's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ZEG to the average of the S&P500 Index (22.70), we can say ZEG is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.65 | ||
| Fwd PE | 14.69 |
4.2 Price Multiples
63.27% of the companies in the same industry are cheaper than ZEG, based on the Enterprise Value to EBITDA ratio.
ZEG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.04 | ||
| EV/EBITDA | 24.59 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ZEG may justify a higher PE ratio.
ZEG's earnings are expected to grow with 12.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.29
PEG (5Y)0.95
EPS Next 2Y13.68%
EPS Next 3Y12.68%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.05%, ZEG has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.04, ZEG pays a bit more dividend than its industry peers.
ZEG's Dividend Yield is comparable with the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.05% |
5.2 History
The dividend of ZEG has a limited annual growth rate of 1.40%.
Dividend Growth(5Y)1.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
59.51% of the earnings are spent on dividend by ZEG. This is a bit on the high side, but may be sustainable.
ZEG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP59.51%
EPS Next 2Y13.68%
EPS Next 3Y12.68%
FRA:ZEG (9/17/2025, 7:00:00 PM)
131.65
+0.8 (+0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners46.88%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap408.18B
Analysts82.94
Price Target156.64 (18.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.05% |
Yearly Dividend2.55
Dividend Growth(5Y)1.4%
DP59.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.79%
Min EPS beat(2)-1.74%
Max EPS beat(2)9.32%
EPS beat(4)2
Avg EPS beat(4)1.9%
Min EPS beat(4)-1.74%
Max EPS beat(4)9.32%
EPS beat(8)4
Avg EPS beat(8)1.17%
EPS beat(12)8
Avg EPS beat(12)2.95%
EPS beat(16)11
Avg EPS beat(16)2.52%
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.99%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-3.99%
Max Revenue beat(4)2.7%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.55%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0.18%
PT rev (3m)-2.78%
EPS NQ rev (1m)0.49%
EPS NQ rev (3m)-2.77%
EPS NY rev (1m)1.07%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.48%
Revenue NQ rev (3m)2.12%
Revenue NY rev (1m)0.98%
Revenue NY rev (3m)1.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.65 | ||
| Fwd PE | 14.69 | ||
| P/S | 8.55 | ||
| P/FCF | 59.04 | ||
| P/OCF | 36.09 | ||
| P/B | 10.8 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.59 |
EPS(TTM)7.46
EY5.67%
EPS(NY)8.96
Fwd EY6.81%
FCF(TTM)2.23
FCFY1.69%
OCF(TTM)3.65
OCFY2.77%
SpS15.4
BVpS12.18
TBVpS-3.93
PEG (NY)1.29
PEG (5Y)0.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.38% | ||
| ROE | 18.55% | ||
| ROCE | 17.47% | ||
| ROIC | 14.26% | ||
| ROICexc | 15.63% | ||
| ROICexgc | 78.69% | ||
| OM | 24.39% | ||
| PM (TTM) | 14.68% | ||
| GM | 82.07% | ||
| FCFM | 14.48% |
ROA(3y)5.35%
ROA(5y)4.19%
ROE(3y)13.78%
ROE(5y)12.42%
ROIC(3y)11.62%
ROIC(5y)9.52%
ROICexc(3y)12.66%
ROICexc(5y)10.55%
ROICexgc(3y)112.76%
ROICexgc(5y)85.06%
ROCE(3y)13.95%
ROCE(5y)11.45%
ROICexcg growth 3Y43.28%
ROICexcg growth 5Y4.77%
ROICexc growth 3Y41%
ROICexc growth 5Y11.99%
OM growth 3Y21.43%
OM growth 5Y8.6%
PM growth 3Y251.6%
PM growth 5Y18.9%
GM growth 3Y3.31%
GM growth 5Y0.47%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 4.01 | ||
| Debt/EBITDA | 1.36 | ||
| Cap/Depr | 76.24% | ||
| Cap/Sales | 9.21% | ||
| Interest Coverage | 10.19 | ||
| Cash Conversion | 64.97% | ||
| Profit Quality | 98.66% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.67 | ||
| Altman-Z | 5.25 |
F-Score7
WACC8.86%
ROIC/WACC1.61
Cap/Depr(3y)61.87%
Cap/Depr(5y)60.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.64%
Profit Quality(3y)144.6%
Profit Quality(5y)772.45%
High Growth Momentum
Growth
EPS 1Y (TTM)22.3%
EPS 3Y15.85%
EPS 5Y18.59%
EPS Q2Q%9.6%
EPS Next Y13.69%
EPS Next 2Y13.68%
EPS Next 3Y12.68%
EPS Next 5Y12.18%
Revenue 1Y (TTM)15%
Revenue growth 3Y13.06%
Revenue growth 5Y17.27%
Sales Q2Q%11.74%
Revenue Next Year9.68%
Revenue Next 2Y7.88%
Revenue Next 3Y7.14%
Revenue Next 5Y6.76%
EBIT growth 1Y37.03%
EBIT growth 3Y37.28%
EBIT growth 5Y27.35%
EBIT Next Year34.44%
EBIT Next 3Y17.32%
EBIT Next 5Y12.64%
FCF growth 1Y24.74%
FCF growth 3Y24.58%
FCF growth 5Y70.22%
OCF growth 1Y31.54%
OCF growth 3Y25.76%
OCF growth 5Y31.92%